Most Read Articles
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
Pearl Toh, 26 Nov 2020
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.
Audrey Abella, 6 days ago
A pilot telemedicine initiative may be an alternative for facilitating delivery of intravenous iron (IVI) for individuals requiring iron supplementation.

Which factors predict biopsy reclassification in men on surveillance for prostate cancer?

18 Nov 2020

High genomic score, prostate-specific antigen (PSA) kinetics, and PSA density 0.15 are predictive of biopsy reclassification within 3 years of commencing active surveillance, according to a study. Moreover, the association of PSA kinetics and PSA density 0.15 with reclassification persists at 5 years following diagnosis.

The authors identified 1,031 men with clinically low-risk prostate cancer prospectively enrolled on active surveillance at the University of California between 2000 and 2016. Biopsy reclassification was defined as Gleason Grade Group 2 or greater on subsequent biopsy.

Factors associated with risk of biopsy reclassification at first surveillance biopsy and 1 to 3, 3 to 5, and 5 to 10 years after enrolment were identified through multivariable Cox proportional hazards regression models, adjusting for clinicodemographic factors, Prostate Imaging Reporting and Data System (PI-RADS) score, and genomic testing.

Multivariable analysis revealed that biopsy reclassification correlated with PSA density 0.15 (hazard ratio [HR], 3.37, 95 percent confidence interval [CI], 1.83–6.21), percentage of biopsy cores positive (HR, 1.27, 95 percent CI, 1.05–1.54), and high genomic score (HR, 2.81, 95 percent CI, 1.21–6.52) at first surveillance biopsy and at 1 to 3 years, after adjustment.

PSA density 0.15 (HR, 2.36, 95 percent CI, 1.56–3.56) and PSA kinetics (HR, 2.19, 95 percent CI, 1.43–3.34) were also associated with reclassification at 3 to 5 years. However, a PI-RADS score of 4­–5 did not correlate with biopsy reclassification at any time point.

“Few validated clinical tools currently exist to standardize the frequency of biopsies for men on active surveillance for low risk prostate cancer,” the authors noted.

Editor's Recommendations
Most Read Articles
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
Pearl Toh, 26 Nov 2020
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.
Audrey Abella, 6 days ago
A pilot telemedicine initiative may be an alternative for facilitating delivery of intravenous iron (IVI) for individuals requiring iron supplementation.